Published in

Bentham Science Publishers, Recent Patents on Inflammation and Allergy Drug Discovery, 3(7), p. 215-222

DOI: 10.2174/1872213x113079990020

Links

Tools

Export citation

Search in Google Scholar

Recent Patents in Autophagy and Immune Response

Journal article published in 2013 by María Peña, Juan Sanctis ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Autophagy is a complex process in which cell homeostasis of proteins, organelles, exocytic and endocytic vacuoles are controlled. There is a direct link between autophagy and cell death with antigen processing, generation of inflammatory response and immune response. In different diseases, deficiencies in autophagy have been reported. In cancer, it has been proposed that autophagy, at its beginnings, is capable of inducing cell death; however, in aggressive tumours and metastasis, the process is responsible for pharmacologic resistance and tumour survival. More research has to be done in order to allow us to understand the process and generate therapeutic options in different pathologies important for the human being. Some patents focused on methodology of autophagosome formation and analysis which seem to be important for pathological description and eventually in future therapeutic approaches have also been reviewed in this article.